The Centers for Medicare & Medicaid Services recently issued a memo clarifying its ligature risk policy, which pertains to environmental safeguards for patients at risk of harm to self or others. The agency expects to release comprehensive guidance for state survey agencies and accrediting organizations in the next six months. Meanwhile, the accrediting body or state agency has authority to determine the level of citation for ligature deficiencies based on its expert opinion, CMS said. According to the clarifying memo, the focus for a ligature “resistant” or ligature “free” environment is primarily aimed at psychiatric hospitals and units, and does not apply to non-psychiatric units of acute care hospitals.

Headline
The Food and Drug Administration has identified a Class I recall of North American Rescue first aid kits containing TRUE METRIX Blood Glucose Monitoring…
Headline
Angela Hewlett, M.D., professor of infectious diseases at the University of Nebraska Medical Center and medical director of the Nebraska Biocontainment Unit,…
Headline
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…
Headline
The Administration for Strategic Preparedness and Response June 16 announced the launch of the Digital Stockpile and Manufacturing Response Network Challenge,…
Headline
Stormee Williams, M.D., senior vice president and chief health equity officer at Children’s Health, shares how her team is identifying food insecurity, why…
Headline
President Trump signed an executive order May 29 that directs the Centers for Disease Control and Prevention and the Advisory Committee on Immunization…